Literature DB >> 24912888

Effects of acute and repeated cocaine on markers for neural plasticity within the mesolimbic system in rats.

Nieves Rodriguez-Espinosa1, Emilio Fernandez-Espejo.   

Abstract

RATIONALE: Repeated cocaine is known to induce morphological changes in dopaminergic circuits that are known to participate on cocaine-induced addictive changes.
OBJECTIVE: The objective of the present study was to discern if acute or repeated regimens of daily cocaine (10 mg/kg) lead to reliable changes in the expression of some protein markers for neural plasticity such as synaptophysin, p21-Arc, alpha-tubulin (α-tubulin), and stathmin, in the mesolimbic dopaminergic circuit. Well-known changes in tyrosine hydroxylase and protein kinase A were used for confirming biochemical effects of repeated cocaine. Animals were subjected to three treatments: acute injection, 3-day injections, or sensitizing cocaine during 3 days followed by challenging doses at days 8 and 18.
RESULTS: The findings revealed that sensitizing regimen of cocaine increases stathmin levels within the nucleus accumbens at day 18 of treatment, not day 8, without changes of synaptophysin, p21-Arc, or α-tubulin. This neural plasticity change seems not to be related to the development of motor sensitization. Other neural regions such as prefrontal cortex, dorsal striatum, and ventral tegmental area were not found to be affected. Repeated cocaine led to well-known short-term augmentation of tyrosine-hydroxylase and protein kinase A expressions in the nucleus accumbens, as well as maintained upregulation of tyrosine hydroxylase in the ventral tegmental area.
CONCLUSIONS: As stathmin is an important regulatory protein of microtubule dynamics, this protein change would be linked to morphological changes after repeated cocaine. It was confirmed that upregulation of tyrosine hydroxylase within the ventral tegmental area may participate on the development of motor sensitization.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24912888     DOI: 10.1007/s00213-014-3632-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  38 in total

Review 1.  Molecular basis of long-term plasticity underlying addiction.

Authors:  E J Nestler
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

2.  Suppressing calcium/calmodulin-dependent protein kinase II activity in the ventral tegmental area enhances the acute behavioural response to cocaine but attenuates the initiation of cocaine-induced behavioural sensitization in rats.

Authors:  Stephanie C Licata; Heath D Schmidt; R Christopher Pierce
Journal:  Eur J Neurosci       Date:  2004-01       Impact factor: 3.386

Review 3.  The roles of calcium/calmodulin-dependent and Ras/mitogen-activated protein kinases in the development of psychostimulant-induced behavioral sensitization.

Authors:  Stephanie C Licata; R Christopher Pierce
Journal:  J Neurochem       Date:  2003-04       Impact factor: 5.372

4.  Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum.

Authors:  Yujing Qin; Qinjie Ouyang; John Pablo; Deborah C Mash
Journal:  Neuroreport       Date:  2005-09-08       Impact factor: 1.837

5.  Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine.

Authors:  J Stewart; P Vezina
Journal:  Brain Res       Date:  1989-08-28       Impact factor: 3.252

6.  Inactivation of Gi and G(o) proteins in nucleus accumbens reduces both cocaine and heroin reinforcement.

Authors:  D W Self; R Z Terwilliger; E J Nestler; L Stein
Journal:  J Neurosci       Date:  1994-10       Impact factor: 6.167

7.  Elevated BDNF after cocaine withdrawal facilitates LTP in medial prefrontal cortex by suppressing GABA inhibition.

Authors:  Hui Lu; Pei-Lin Cheng; Byung Kook Lim; Nina Khoshnevisrad; Mu-Ming Poo
Journal:  Neuron       Date:  2010-09-09       Impact factor: 17.173

Review 8.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

9.  Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels.

Authors:  S L Vrana; K E Vrana; T R Koves; J E Smith; S I Dworkin
Journal:  J Neurochem       Date:  1993-12       Impact factor: 5.372

10.  Isotypes of alpha-tubulin are differentially regulated during neuronal maturation.

Authors:  F D Miller; C C Naus; M Durand; F E Bloom; R J Milner
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

View more
  4 in total

1.  Transcriptomic profiling of the ventral tegmental area and nucleus accumbens in rhesus macaques following long-term cocaine self-administration.

Authors:  Eric J Vallender; Dharmendra B Goswami; Nina M Shinday; Susan V Westmoreland; Wei-Dong Yao; James K Rowlett
Journal:  Drug Alcohol Depend       Date:  2017-03-18       Impact factor: 4.492

2.  Initial Evaluations of the Microtubule-Based PET Radiotracer, [11C]MPC-6827 in a Rodent Model of Cocaine Abuse.

Authors:  Naresh Damuka; Thomas J Martin; Avinash H Bansode; Ivan Krizan; Conner W Martin; Mack Miller; Christopher T Whitlow; Michael A Nader; Kiran Kumar Solingapuram Sai
Journal:  Front Med (Lausanne)       Date:  2022-02-28

3.  Single cocaine exposure does not alter striatal pre-synaptic dopamine function in mice: an [18 F]-FDOPA PET study.

Authors:  David R Bonsall; Michelle Kokkinou; Mattia Veronese; Christopher Coello; Lisa A Wells; Oliver D Howes
Journal:  J Neurochem       Date:  2017-10-26       Impact factor: 5.372

4.  Social stress during adolescence activates long-term microglia inflammation insult in reward processing nuclei.

Authors:  Marta Rodríguez-Arias; Sandra Montagud-Romero; Ana María Guardia Carrión; Carmen Ferrer-Pérez; Ana Pérez-Villalba; Eva Marco; Meritxell López Gallardo; María-Paz Viveros; José Miñarro
Journal:  PLoS One       Date:  2018-10-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.